Literature DB >> 11870629

CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance.

Koh-Hei Sonoda1, Joan Stein-Streilein.   

Abstract

CD1d-reactive NKT cells are required for the development of antigen-specific T regulatory (Tr) cells responsible for mediating systemic tolerance induced through an immune privileged site such as the eye. The aim of this study was to elucidate the cellular source of CD1d needed for NKT cell activation. Transforming growth factor beta (TGF beta)-2-treated peritoneal exudate cells (PEC) functionally resemble "eye-derived" antigen-presenting cells (APC) and contribute to the generation of Tr cells both in vitro and in vivo. However, when TGF beta-2-treated PEC were pretreated with CD1d-specific antibodies or lacked CD1d expression they failed to induce Tr cells. In addition, we show that the subpopulation of marginal zone (MZ) B cells within the spleen is necessary for induction of Tr cells and that they also must express CD1d. The role of MZ B in tolerance is novel and previously unexplored. Thus, CD1d is necessarily expressed on putative eye-derived APC and splenic MZ B cells for efficient generation of Tr cells in CD1d-reactive NKT cell-dependent tolerance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11870629     DOI: 10.1002/1521-4141(200203)32:3<848::AID-IMMU848>3.0.CO;2-I

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  36 in total

Review 1.  Tolerance and autoimmunity in the eye: a role for CD8 T cells in organ-specific autoimmunity in the retina.

Authors:  John V Forrester; Richard J Cornall
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

2.  CD1d and invariant NKT cells at the human maternal-fetal interface.

Authors:  Jonathan E Boyson; Basya Rybalov; Louise A Koopman; Mark Exley; Steven P Balk; Frederick K Racke; Frederick Schatz; Rachel Masch; S Brian Wilson; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

Review 3.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

4.  The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation.

Authors:  Koh-Hei Sonoda; Taiji Sakamoto; Hong Qiao; Toshio Hisatomi; Toru Oshima; Chikako Tsutsumi-Miyahara; Mark Exley; Steven P Balk; Masaru Taniguchi; Tatsuro Ishibashi
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

5.  Natural killer T cells and innate immune B cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies.

Authors:  Tsuyoshi Takahashi; Samuel Strober
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

6.  Integration of B cells and CD8+ T in the protective regulation of systemic epithelial inflammation.

Authors:  Bo Wei; Michael McPherson; Olga Turovskaya; Peter Velazquez; Daisuke Fujiwara; Sarah Brewer; Jonathan Braun
Journal:  Clin Immunol       Date:  2008-02-20       Impact factor: 3.969

Review 7.  NKT cells at the maternal-fetal interface.

Authors:  J E Boyson; I Aktan; D A Barkhuff; A Chant
Journal:  Immunol Invest       Date:  2008       Impact factor: 3.657

Review 8.  The role of NKT cells in tumor immunity.

Authors:  Masaki Terabe; Jay A Berzofsky
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

9.  Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.

Authors:  Gediminas Matulis; Joseph P Sanderson; Nikolai M Lissin; Maria B Asparuhova; Gopal R Bommineni; Daniel Schümperli; Richard R Schmidt; Peter M Villiger; Bent K Jakobsen; Stephan D Gadola
Journal:  PLoS Biol       Date:  2010-06-22       Impact factor: 8.029

10.  B7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells.

Authors:  Carolin Brandl; Sonja Ortler; Thomas Herrmann; Susanna Cardell; Manfred B Lutz; Heinz Wiendl
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.